Background: Staphylococcus aureus is responsible of a wide range of both community and Hospital acquired infections. Several genomic variability underlie the diversity of S. aureus strains responsible for the emergence of antibiotic resistance. Objective: To assess the prevalence and antibiotic resistance pattern of community acquired S. aureus isolated from pus samples in patients received at the traumatology unit of Our Lady of Health Centre of Batseng'la in Dschang, Western Cameroon. Study Design: This was a descriptive cross-sectional study, carried out over a period of five months (from January to May 2021) involving a total of 52 participants received at the traumatology unit of Our Lady of Health Centre of Batseng'la in Dschang, Western Cameroon. Methods: Pus samples collected from participants were seeded on Chapman Agar at 37°C for 24 hours. The colonies identification was based on catalase, coagulase and DNAse tests. The antibiotic susceptibility test was performed using the Kirby Bauer disk diffusion method on Mueller-Hinton agar. Data were analysed using SPSS version 25 Software. Results: S. aureus was isolated in 22 of the 54 pus samples analysed, giving a positivity rate of 42.3%. The majority of strains (63.6%) were isolated from subjects less than 21 years old. From the strains isolated, 40.9% were MRSA and 86.4% presented multi-resistance patterns to the antibiotics tested. All strains of MRSA were found to be cross-resistant with one or more other antibiotics. Conclusion: The multi-resistance of community acquired S. aureus to antibiotics is a reality. Adequate care should be taken while handling suppurating wounds and abscesses. Especially in younger ager individuals, as this may help in timely setting up proper care and treatment protocols necessary to overcome drug resistance of such extremely flexible pathogens.
Background: Chlamydia trachomatis is the most common cause of sexually transmitted infections worldwide. Infections caused by this pathogen are usually symptomatic in men and asymptomatic in about 2/3 of women resulting in a variety of clinical complications. Aim: To determine the seroprevalence of immunological markers and the risk factors associated with the seropositivity to C. trachomatis infection in sexually active individuals visiting the Saint Vincent de Paul Hospital in Dschang, West region Cameroon Study Design: This was an analytical cross-sectional study conducted between July and September 2020 at Saint Vincent de Paul Hospital in Dschang, Cameroon. Methods: A total of 154 participants were recruited during the data collection period. An indirect ELISA method was used to analyse participant’s serum samples. Risk factors were assessed through univariate and multivariate logistic regression using SPSS 25. Results: The seroprevalence of C. trachomatis infection was 38.3% (95%CI: 30.6 - 46.0). Only 39.6% (95%CI: 31.6 - 47.3) of the study population had never been in contact with the bacterium. The reinfection rate among participants was 8.4% (95%CI: 4.0 - 12.8). Results revealed that being Male is a protective factor against the infection [aOR: 0.12; 95% CI: 0.03 - 0.56; P ꞊ .007]. The non-use of condom [aOR: 21.58; 95% CI: 3.53 – 132.06; P ꞊ .001] and having encountered three or more sexual partners [aOR: 9.90; 95%CI: 1.07 – 91.60; P ꞊ .043] were the significant predictors of Chlamydia seropositivity. Conclusion: The implementation of proactive strategies to curb down the spread of the infection is necessary in this locality. This can be done by providing NAATs to as many health facilities as possible, educating the population and standardizing treatment protocols.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.